For instance, in a mouse xenograft model, GLO1-depleted breast cancers showed increased tumorigenic and metastatic potential and similarly, increased aggressiveness of colorectal cancer patients’ cancer cells inversely correlated with GLO1 activity (85, 86). Here, GLO1 is linked to breast carcinoma.